Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension
- 1 June 2012
- journal article
- Published by Elsevier in Nitric Oxide
- Vol. 27 (1) , 1-8
Abstract
No abstract availableKeywords
Funding Information
- NIH (HL 62000, HL 77421)
This publication has 82 references indexed in Scilit:
- Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signallingCardiovascular Research, 2010
- Mitochondrial aldehyde dehydrogenase mediates vasodilator responses of glyceryl trinitrate and sodium nitrite in the pulmonary vascular bed of the ratAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Clinical translation of nitrite therapy for cardiovascular diseasesNitric Oxide, 2010
- Nitrite directly vasodilates hypoxic vasculature via nitric oxide‐dependent and ‐independent pathwaysBritish Journal of Pharmacology, 2009
- Analysis of Pulmonary Vasodilator Responses to SB-772077-B [4-(7-((3-Amino-1-pyrrolidinyl)carbonyl)-1-ethyl-1H-imidazo(4,5-c)pyridin-2-yl)-1,2,5-oxadiazol-3-amine], a Novel Aminofurazan-Based Rho Kinase InhibitorThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the ratAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troublesBritish Journal of Pharmacology, 2008
- Bioactivation of Nitroglycerin by Purified Mitochondrial and Cytosolic Aldehyde DehydrogenasesJournal of Biological Chemistry, 2008
- A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasisNature Chemical Biology, 2008
- Clinical classification of pulmonary hypertensionJACC, 2004